Leibniz-Institut Fur Virologie

Leibniz-Institut Fur Virologie is a research organisation in Hamburg, Germany that has taken part in 16 EU-funded projects since 2010, receiving €9.8M in EU funding and leading 6 as coordinator.

EU funding received€9.8M
EU projects16
As coordinator6
Running now6
First EU project2010
Latest project2027
CountryGermany
EU registration (PIC)991028049
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Leibniz-Institut Fur Virologie's own share of each project, not the project's full budget.

  • Horizon 2020€7.1M · 8 projects
  • Horizon Europe€2.2M · 5 projects
  • FP7 (2007 to 2013)€452k · 2 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

16 EU-funded projects, newest first. Leibniz-Institut Fur Virologie led 6 of them as coordinator. Each links to the official record.

  • VIBESPartner

    Integrating virology, artificial intelligence and biophotonics for innovative antiviral strategies against emerging flaviviruses

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €290ktheir share
  • DEFENDERCoordinator

    Identification of novel viral entry factors and development of antiviral approaches

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €1.3Mtheir share
  • SPIDoc'sAssociated partner

    The Next Generation MS SPIDoc’s

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • AIOIACoordinator

    AI Organoid Image Analysis

    Horizon Europe · 2023–2024 · Project on CORDIS ↗

    €150ktheir share
  • EUGLOH 2.0Associated partner

    European University Alliance for Global Health - Part 2.0

    Erasmus+ (ERASMUS+) · 2023–2026 · Project on the EU portal ↗

  • HORUSPartner

    Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €504ktheir share
  • ARIADNEPartner

    Redefining mass spectrometry – a breakthrough platform for real-time noninvasive breath analysis with single ion detection of intact viruses and bacteria and post-analysis molecular characterization

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • RegNKCoordinator

    Regulation of NK cell function

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €2.5Mtheir share
  • MS SPIDOCCoordinator

    Mass Spectrometry for Single Particle Imaging of Dipole Oriented protein Complexes

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €499ktheir share
  • SPOCkS MSCoordinator

    Sampling Protein cOmplex Conformational Space with native top down Mass Spectrometry

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €2.0Mtheir share
  • PEVIAPartner

    PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €81ktheir share
  • EBOPATHPartner

    Evaluation of species-specific ebolavirus pathophysiology in xenochimeric mice

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €100ktheir share
  • VIRUSCANPartner

    Optomechanics for Virology

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

    €883ktheir share
  • EHVAPartner

    European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

    €993ktheir share
  • HIV-NOPACoordinator

    Assessment of functional immune responses of HIV infected individuals without protective HLA-B alleles

    FP7 (2007 to 2013) · 2015–2017 · Project on CORDIS ↗

    €252ktheir share
  • FLU-PHARMPartner

    New drugs targeting influenza virus polymerase

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €200ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • antivirals
  • automation
  • bacteriology
  • cavity optomechanics
  • coronaviruses
  • data science
  • drug discovery
  • ebola
  • electron microscopy
  • genomes
  • immunology
  • immunotherapy
  • influenza

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime